Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
Provided By GlobeNewswire
Last update: Mar 20, 2025
CAMBRIDGE, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period and full year ended December 31, 2024, and provided a business update.
Read more at globenewswire.com
